InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.25
(
0.00%
)
US TECH 100
19,018.00
(
0.09%
)
Dow Jones
40,659.76
(
0.00%
)
Brent Oil
79.19
(
0.44%
)
Bitcoin
58,690.97
(
0.17%
)
Post# of 43260
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cowtown jay

Send PM Follow Ignore
Followers 87
Posts 6808
Boards Moderated 1
Alias Born 09/18/2009

cowtown jay

Re: None

Friday, 02/02/2024 1:40:30 AM

Friday, February 02, 2024 1:40:30 AM

Post# of 43260
Good luck to CtyoDyn on the resubmission of their revised HIV clinical trial protocol to the FDA. They also announced that their partnership with Montefiore and Albert Einstein College plans to move forward with a pre-clinical trial designed to study leronlimab in glioblastoma, which is also an indication that Humanigen has studied for treatment. It's good to see researchers focus on immunomodulators as treatment therapeutics for these indications.

https://www.globenewswire.com/news-release/2024/02/01/2821970/19782/en/CytoDyn-Announces-Submission-of-Clinical-Protocol-to-FDA-and-Initiation-of-Pre-Clinical-Study-in-Glioblastoma.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up